Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman Sells 3,496 Shares of Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 3,496 shares of Phreesia stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $29.72, for a total value of $103,901.12. Following the sale, the general counsel now directly owns 142,630 shares of the company’s stock, valued at $4,238,963.60. This represents a 2.39 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Phreesia Stock Down 4.0 %

Shares of NYSE:PHR opened at $28.49 on Friday. The company has a market capitalization of $1.66 billion, a price-to-earnings ratio of -19.38 and a beta of 0.96. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $30.53. The business’s 50-day moving average is $27.22 and its 200-day moving average is $23.80. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same quarter last year, the business posted ($0.58) earnings per share. The firm’s revenue was up 16.6% compared to the same quarter last year. Equities research analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Institutional Investors Weigh In On Phreesia

Several large investors have recently bought and sold shares of the business. Johnson Financial Group Inc. boosted its position in shares of Phreesia by 381.3% during the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock worth $28,000 after acquiring an additional 896 shares during the last quarter. R Squared Ltd purchased a new position in shares of Phreesia during the 4th quarter worth about $30,000. International Assets Investment Management LLC boosted its holdings in Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after acquiring an additional 1,395 shares during the period. BankPlus Trust Department bought a new stake in shares of Phreesia during the fourth quarter valued at approximately $34,000. Finally, Quarry LP grew its position in shares of Phreesia by 210.9% during the 4th quarter. Quarry LP now owns 2,835 shares of the company’s stock worth $71,000 after buying an additional 1,923 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

PHR has been the topic of a number of analyst reports. Robert W. Baird dropped their price target on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 11th. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and raised their price target for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. Needham & Company LLC reiterated a “buy” rating and set a $29.00 price target on shares of Phreesia in a research note on Friday, January 10th. KeyCorp lifted their price target on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, January 8th. Finally, JMP Securities restated a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Thirteen research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $31.15.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.